ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Abbisko Therapeutics and Lilly partner to develop new molecules
January 19, 2022Abbisko is eligible to receive up to $258m in milestone payments from Lilly. -
Abbisko Therapeutics Announces Worldwide Collaboration with Lilly to Discover and Develop Novel Molecules
January 18, 2022Collaboration Combines Abbisko Therapeutics' Proprietary Drug Discovery Platform with Lilly's Disease and Discovery Expertise. Abbisko Therapeutics Is Eligible to Receive Research, Development and Commercial Milestone Payments. -
Abbisko and Sperogenix Announce An Exclusive Agreement to Develop ABSK021 for ALS and Other Rare Neurological Diseases in Greater China
July 05, 2021Sperogenix (Shanghai) MedTech Co., Ltd., a subsidiary of Sperogenix Therapeutics (platform company for development and commercialization of rare diseases medications in China), has entered into an exclusive licensing agreement with Abbisko ...
Pharma Sources Insight January 2025
